In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...

A potential world-first cure for hepatitis B, a breakthrough treatment for a rare, life-threatening childhood disease, and a ...

NY state is investing $1 million into Ithaca's SouthWorks development, which will build 915 residences on 900,000 square feet ...

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on ...